|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/21 | |
| A61K 35/17 | |||
| A61K 39/00 | |||
| A61K 38/20 |
| (11) | Patento numeris | 1996232 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 07751592.2 |
| Europos patento paraiškos padavimo data | 2007-02-23 | |
| (97) | Europos patento paraiškos paskelbimo data | 2008-12-03 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-04-06 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2007/004841 |
| Data | 2007-02-23 |
| (87) | Numeris | WO 2007/103009 |
| Data | 2007-09-13 |
| (30) | Numeris | Data | Šalis |
| 778516 P | 2006-03-01 | US |
| (72) |
CAI, Zeling, US
MORIARTY, Ann, US
PETERSON, Per, A., US
RICHARDS, Jon, M., US
|
| (73) |
Janssen Pharmaceutica N.V.,
Turnhoutseweg 30, 2340 Beerse,
BE
|
| (54) | CANCER TREATMENT COMBINING LYMPHODEPLETING AGENT WITH CTLs AND CYTOKINES |
| CANCER TREATMENT COMBINING LYMPHODEPLETING AGENT WITH CTLs AND CYTOKINES |